Before joining Questcor in November 2009, Sian Bigora served as Vice President, Clinical Research and Regulatory Affairs at AGI Therapeutics plc since 2007. Dr. Bigora managed her own consulting practice in regulatory and product development strategy prior to joining AGI. She served in various leadership capacities with GloboMax since its founding in 1997. Previously, she was a Pharmacokinetic Specialist at the University of Maryland, School of Pharmacy and served as Acting Managing Director of the Clinical Research Unit at that institution. Dr. Bigora served as a regulatory representative for AGI and other sponsors at the Food and Drug Administration (FDA) in various therapeutics areas such as Central Nervous System diseases and disorders, Gastrointestinal diseases, Cardiovascular diseases and Analgesics. She has been an active presenter and publisher in her field since 1992.